Strides Pharma Science Ltd.
•₹ 986.2-0.68%
2026-08-21
PROS
- Promoters have been increasing their shareholding - up 2.1pp over 2 years
- Latest quarter profit grew 446.3% YoY, showing strong momentum
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 3.14x)
- Company generates healthy free cash flow
- Attractively priced for its growth - PEG of 0.2
- Institutional investors have been accumulating - FII+DII up 2.5pp
CONS
- A large part of profit comes from other income (101.4% of PBT)
- Company has a low return on equity of 2.2% over last 3 years
- Company has a low return on capital employed of 4.8%
- Company has delivered a poor sales growth of 3.3% over past five years
- Recurring exceptional / one-off items are inflating headline profit
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 3620.70 | 2139.42 | 20263.10 | 1191.00 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | STAR | 957.00 | 14.38 | 8820.93 | 0.52 | 165.49 | 56.73 | 1265.41 | 13.01 | 18.57 | 18.06 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 475 | 553 | 380 | 603 | 513 | 520 | 551 | 556 | 499 | 522 | 554 | 606 | 583 | |
| 420 | 514 | 378 | 492 | 448 | 464 | 477 | 488 | 431 | 460 | 472 | 531 | 576 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 12 | 19 | 5 | 26 | 8 | 24 | 2 | 12 | 2 | 14 | 103 | 4 | 1 |
| Interest | 37 | 42 | 36 | 39 | 41 | 42 | 34 | 29 | 30 | 29 | 27 | 27 | 29 |
| Depreciation | 21 | 23 | 22 | 22 | 21 | 21 | 21 | 22 | 22 | 22 | 22 | 25 | 26 |
| 9 | -7 | -57 | 76 | 12 | 16 | 21 | 28 | 16 | 25 | 135 | 27 | 85 | |
| Tax % | 12.38% | 1.46% | -6.35% | -3.72% | 9.75% | -5.37% | 30.12% | 43.08% | 18.66% | -26.19% | 9.58% | 38.33% | 13.96% |
| Net Profit | 8 | -7 | -60 | 79 | 11 | 17 | 15 | 16 | 13 | 32 | 122 | 16 | 73 |
| 1 | -1 | -7 | 9 | 1 | 2 | 2 | 2 | 1 | 3 | 13 | 2 | 1 | |
| Equity Capital | 92 | 90 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 92 | 90 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 475
- 420
- Operating Profit
- —
- OPM %
- —
- Other Income
- 12
- Interest
- 37
- Depreciation
- 21
- 9
- Tax %
- 12.38%
- Net Profit
- 8
- 1
- Equity Capital
- 92
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 92
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 553
- 514
- Operating Profit
- —
- OPM %
- —
- Other Income
- 19
- Interest
- 42
- Depreciation
- 23
- -7
- Tax %
- 1.46%
- Net Profit
- -7
- -1
- Equity Capital
- 90
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 90
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 380
- 378
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 36
- Depreciation
- 22
- -57
- Tax %
- -6.35%
- Net Profit
- -60
- -7
- Equity Capital
- 92
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 92
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 603
- 492
- Operating Profit
- —
- OPM %
- —
- Other Income
- 26
- Interest
- 39
- Depreciation
- 22
- 76
- Tax %
- -3.72%
- Net Profit
- 79
- 9
- Equity Capital
- 92
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 92
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 513
- 448
- Operating Profit
- —
- OPM %
- —
- Other Income
- 8
- Interest
- 41
- Depreciation
- 21
- 12
- Tax %
- 9.75%
- Net Profit
- 11
- 1
- Equity Capital
- 92
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 92
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 520
- 464
- Operating Profit
- —
- OPM %
- —
- Other Income
- 24
- Interest
- 42
- Depreciation
- 21
- 16
- Tax %
- -5.37%
- Net Profit
- 17
- 2
- Equity Capital
- 92
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 92
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 551
- 477
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 34
- Depreciation
- 21
- 21
- Tax %
- 30.12%
- Net Profit
- 15
- 2
- Equity Capital
- 92
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 92
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 556
- 488
- Operating Profit
- —
- OPM %
- —
- Other Income
- 12
- Interest
- 29
- Depreciation
- 22
- 28
- Tax %
- 43.08%
- Net Profit
- 16
- 2
- Equity Capital
- 92
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 92
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 499
- 431
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 30
- Depreciation
- 22
- 16
- Tax %
- 18.66%
- Net Profit
- 13
- 1
- Equity Capital
- 92
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 92
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 522
- 460
- Operating Profit
- —
- OPM %
- —
- Other Income
- 14
- Interest
- 29
- Depreciation
- 22
- 25
- Tax %
- -26.19%
- Net Profit
- 32
- 3
- Equity Capital
- 92
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 92
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 554
- 472
- Operating Profit
- —
- OPM %
- —
- Other Income
- 103
- Interest
- 27
- Depreciation
- 22
- 135
- Tax %
- 9.58%
- Net Profit
- 122
- 13
- Equity Capital
- 92
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 92
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 606
- 531
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 27
- Depreciation
- 25
- 27
- Tax %
- 38.33%
- Net Profit
- 16
- 2
- Equity Capital
- 92
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 92
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 583
- 576
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 29
- Depreciation
- 26
- 85
- Tax %
- 13.96%
- Net Profit
- 73
- 1
- Equity Capital
- 92
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 92
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,382 | 1,470 | 1,537 | 1,692 | 1,858 | 1,979 | 1,854 | 1,866 | 2,139 | 2,180 | 2,264 | |
| 1,211 | 1,273 | 1,398 | 1,487 | 1,698 | 1,902 | 1,772 | 1,724 | 1,888 | 1,978 | 2,039 | |
| Operating Profit | 340 | 353 | 254 | 298 | 276 | 200 | 183 | 209 | 309 | 408 | — |
| OPM % | 25 | 24 | 16 | 18 | 15 | 10 | 10 | 11 | 14 | 19 | — |
| Other Income | 169 | 156 | 115 | 93 | 117 | 123 | 100 | 67 | 57 | 206 | 123 |
| Interest | 72 | 82 | 54 | 67 | 65 | 74 | 139 | 139 | 146 | 114 | 112 |
| Depreciation | 70 | 78 | 83 | 94 | 99 | 104 | 94 | 87 | 85 | 91 | 95 |
| 183 | 164 | 113 | 136 | 112 | 22 | -65 | -23 | 78 | 203 | 271 | |
| Tax % | 17 | 5 | -1 | 12 | 30 | -738 | 107 | -6 | 24 | 10 | 10 |
| Net Profit | 152 | 156 | 114 | 120 | 78 | 180 | 5 | -24 | 59 | 184 | 243 |
| EPS | 12 | 100 | 12 | 13 | 9 | 20 | 1 | -3 | 6 | 20 | — |
| Dividend Payout % | 26 | 11 | 23 | 104 | 29 | 0 | 289 | -95 | 62 | 25 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 17 | 17 | 13 | 13 | 9 | 20 | 1 | -3 | 6 | 20 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 17 | 17 | 13 | 13 | 9 | 20 | 1 | -3 | 6 | 20 | — |
Mar 2017
- 1,382
- 1,211
- Operating Profit
- 340
- OPM %
- 25
- Other Income
- 169
- Interest
- 72
- Depreciation
- 70
- 183
- Tax %
- 17
- Net Profit
- 152
- EPS
- 12
- Dividend Payout %
- 26
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 17
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 17
Mar 2018
- 1,470
- 1,273
- Operating Profit
- 353
- OPM %
- 24
- Other Income
- 156
- Interest
- 82
- Depreciation
- 78
- 164
- Tax %
- 5
- Net Profit
- 156
- EPS
- 100
- Dividend Payout %
- 11
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 17
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 17
Mar 2019
- 1,537
- 1,398
- Operating Profit
- 254
- OPM %
- 16
- Other Income
- 115
- Interest
- 54
- Depreciation
- 83
- 113
- Tax %
- -1
- Net Profit
- 114
- EPS
- 12
- Dividend Payout %
- 23
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 13
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 13
Mar 2020
- 1,692
- 1,487
- Operating Profit
- 298
- OPM %
- 18
- Other Income
- 93
- Interest
- 67
- Depreciation
- 94
- 136
- Tax %
- 12
- Net Profit
- 120
- EPS
- 13
- Dividend Payout %
- 104
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 13
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 13
Mar 2021
- 1,858
- 1,698
- Operating Profit
- 276
- OPM %
- 15
- Other Income
- 117
- Interest
- 65
- Depreciation
- 99
- 112
- Tax %
- 30
- Net Profit
- 78
- EPS
- 9
- Dividend Payout %
- 29
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
Mar 2022
- 1,979
- 1,902
- Operating Profit
- 200
- OPM %
- 10
- Other Income
- 123
- Interest
- 74
- Depreciation
- 104
- 22
- Tax %
- -738
- Net Profit
- 180
- EPS
- 20
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 20
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 20
Mar 2023
- 1,854
- 1,772
- Operating Profit
- 183
- OPM %
- 10
- Other Income
- 100
- Interest
- 139
- Depreciation
- 94
- -65
- Tax %
- 107
- Net Profit
- 5
- EPS
- 1
- Dividend Payout %
- 289
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2024
- 1,866
- 1,724
- Operating Profit
- 209
- OPM %
- 11
- Other Income
- 67
- Interest
- 139
- Depreciation
- 87
- -23
- Tax %
- -6
- Net Profit
- -24
- EPS
- -3
- Dividend Payout %
- -95
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -3
Mar 2025
- 2,139
- 1,888
- Operating Profit
- 309
- OPM %
- 14
- Other Income
- 57
- Interest
- 146
- Depreciation
- 85
- 78
- Tax %
- 24
- Net Profit
- 59
- EPS
- 6
- Dividend Payout %
- 62
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
Mar 2026
- 2,180
- 1,978
- Operating Profit
- 408
- OPM %
- 19
- Other Income
- 206
- Interest
- 114
- Depreciation
- 91
- 203
- Tax %
- 10
- Net Profit
- 184
- EPS
- 20
- Dividend Payout %
- 25
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 20
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 20
TTM
- 2,264
- 2,039
- Operating Profit
- —
- OPM %
- —
- Other Income
- 123
- Interest
- 112
- Depreciation
- 95
- 271
- Tax %
- 10
- Net Profit
- 243
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 0%
- 5 Years:
- 3%
- 3 Years:
- 6%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- 3%
- 5 Years:
- 19%
- 3 Years:
- 240%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- 13%
RETURN ON EQUITY
- 10 Years:
- 3%
- 5 Years:
- 2%
- 3 Years:
- 2%
- Last Year:
- 6%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 89 | 90 | 90 | 90 | 90 | 90 | 90 | 92 | 92 | 92 |
| 3,134 | 3,063 | 3,160 | 3,063 | 3,154 | 3,314 | 3,345 | 3,433 | 3,100 | 3,191 | |
| 839 | 604 | 809 | 853 | 731 | 1,120 | 1,064 | 1,334 | 952 | 916 | |
| Trade Payables | 471 | 391 | 509 | 490 | 735 | 644 | 643 | 544 | 485 | 686 |
| 929 | 84 | 15 | 81 | 436 | 188 | 381 | 381 | 302 | 397 | |
| Total Liabilities | 5,462 | 4,232 | 4,583 | 4,576 | 5,146 | 5,356 | 5,525 | 5,783 | 4,931 | 5,282 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 1,124 | 498 | 497 | 578 | 577 | 604 | 584 | 736 | 756 | 785 | |
| Capital Work in Progress | 100 | 87 | 73 | 89 | 81 | 30 | 16 | 71 | 66 | 84 |
| 2,520 | 1,777 | 2,149 | 2,171 | 2,395 | 2,400 | 2,492 | 2,364 | 1,848 | 1,868 | |
| 410 | 270 | 473 | 463 | 689 | 513 | 491 | 498 | 432 | 580 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,565 | 1,453 | 1,521 | |
| Cash & Bank | 95 | 80 | 181 | 110 | 73 | 14 | 86 | 115 | 30 | 41 |
| 1,214 | 1,521 | 1,210 | 1,165 | 1,331 | 1,794 | 1,856 | 434 | 346 | 402 | |
| Total Assets | 5,462 | 4,232 | 4,583 | 4,576 | 5,146 | 5,356 | 5,525 | 5,783 | 4,931 | 5,282 |
| Total Debt | 1,608 | 606 | 809 | 853 | 879 | 1,245 | 1,349 | 1,632 | 1,156 | 1,148 |
| Net Working Capital | 1,145 | 362 | 275 | -61 | 153 | 134 | 330 | 326 | 516 | 534 |
| Contingent Liabilities | 5,396 | 4,411 | 5,724 | 3,478 | 1,792 | 1,706 | 1,313 | 773 | 205 | 166 |
| Book Value per Share | 360.50 | 352.29 | 362.84 | 352.04 | 361.65 | 379.13 | 380.46 | 383.52 | 346.37 | 356.17 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 1,608 | 606 | 809 | 853 | 879 | 1,245 | 1,349 | 1,632 | 1,156 | 1,148 |
| Net Working Capital | 1,145 | 362 | 275 | -61 | 153 | 134 | 330 | 326 | 516 | 534 |
| Contingent Liabilities | 5,396 | 4,411 | 5,724 | 3,478 | 1,792 | 1,706 | 1,313 | 773 | 205 | 166 |
| Book Value per Share | 360.50 | 352.29 | 362.84 | 352.04 | 361.65 | 379.13 | 380.46 | 383.52 | 346.37 | 356.17 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2017
- Equity Capital
- 89
- 3,134
- 839
- Trade Payables
- 471
- 929
- Total Liabilities
- 5,462
- 1,124
- Capital Work in Progress
- 100
- 2,520
- 410
- 0
- Cash & Bank
- 95
- 1,214
- Total Assets
- 5,462
- Total Debt
- 1,608
- Net Working Capital
- 1,145
- Contingent Liabilities
- 5,396
- Book Value per Share
- 360.50
- Face Value
- 10.00
- Total Debt
- 1,608
- Net Working Capital
- 1,145
- Contingent Liabilities
- 5,396
- Book Value per Share
- 360.50
- Face Value
- 10.00
Mar 2018
- Equity Capital
- 90
- 3,063
- 604
- Trade Payables
- 391
- 84
- Total Liabilities
- 4,232
- 498
- Capital Work in Progress
- 87
- 1,777
- 270
- 0
- Cash & Bank
- 80
- 1,521
- Total Assets
- 4,232
- Total Debt
- 606
- Net Working Capital
- 362
- Contingent Liabilities
- 4,411
- Book Value per Share
- 352.29
- Face Value
- 10.00
- Total Debt
- 606
- Net Working Capital
- 362
- Contingent Liabilities
- 4,411
- Book Value per Share
- 352.29
- Face Value
- 10.00
Mar 2019
- Equity Capital
- 90
- 3,160
- 809
- Trade Payables
- 509
- 15
- Total Liabilities
- 4,583
- 497
- Capital Work in Progress
- 73
- 2,149
- 473
- 0
- Cash & Bank
- 181
- 1,210
- Total Assets
- 4,583
- Total Debt
- 809
- Net Working Capital
- 275
- Contingent Liabilities
- 5,724
- Book Value per Share
- 362.84
- Face Value
- 10.00
- Total Debt
- 809
- Net Working Capital
- 275
- Contingent Liabilities
- 5,724
- Book Value per Share
- 362.84
- Face Value
- 10.00
Mar 2020
- Equity Capital
- 90
- 3,063
- 853
- Trade Payables
- 490
- 81
- Total Liabilities
- 4,576
- 578
- Capital Work in Progress
- 89
- 2,171
- 463
- 0
- Cash & Bank
- 110
- 1,165
- Total Assets
- 4,576
- Total Debt
- 853
- Net Working Capital
- -61
- Contingent Liabilities
- 3,478
- Book Value per Share
- 352.04
- Face Value
- 10.00
- Total Debt
- 853
- Net Working Capital
- -61
- Contingent Liabilities
- 3,478
- Book Value per Share
- 352.04
- Face Value
- 10.00
Mar 2021
- Equity Capital
- 90
- 3,154
- 731
- Trade Payables
- 735
- 436
- Total Liabilities
- 5,146
- 577
- Capital Work in Progress
- 81
- 2,395
- 689
- 0
- Cash & Bank
- 73
- 1,331
- Total Assets
- 5,146
- Total Debt
- 879
- Net Working Capital
- 153
- Contingent Liabilities
- 1,792
- Book Value per Share
- 361.65
- Face Value
- 10.00
- Total Debt
- 879
- Net Working Capital
- 153
- Contingent Liabilities
- 1,792
- Book Value per Share
- 361.65
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 90
- 3,314
- 1,120
- Trade Payables
- 644
- 188
- Total Liabilities
- 5,356
- 604
- Capital Work in Progress
- 30
- 2,400
- 513
- 0
- Cash & Bank
- 14
- 1,794
- Total Assets
- 5,356
- Total Debt
- 1,245
- Net Working Capital
- 134
- Contingent Liabilities
- 1,706
- Book Value per Share
- 379.13
- Face Value
- 10.00
- Total Debt
- 1,245
- Net Working Capital
- 134
- Contingent Liabilities
- 1,706
- Book Value per Share
- 379.13
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 90
- 3,345
- 1,064
- Trade Payables
- 643
- 381
- Total Liabilities
- 5,525
- 584
- Capital Work in Progress
- 16
- 2,492
- 491
- 0
- Cash & Bank
- 86
- 1,856
- Total Assets
- 5,525
- Total Debt
- 1,349
- Net Working Capital
- 330
- Contingent Liabilities
- 1,313
- Book Value per Share
- 380.46
- Face Value
- 10.00
- Total Debt
- 1,349
- Net Working Capital
- 330
- Contingent Liabilities
- 1,313
- Book Value per Share
- 380.46
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 92
- 3,433
- 1,334
- Trade Payables
- 544
- 381
- Total Liabilities
- 5,783
- 736
- Capital Work in Progress
- 71
- 2,364
- 498
- 1,565
- Cash & Bank
- 115
- 434
- Total Assets
- 5,783
- Total Debt
- 1,632
- Net Working Capital
- 326
- Contingent Liabilities
- 773
- Book Value per Share
- 383.52
- Face Value
- 10.00
- Total Debt
- 1,632
- Net Working Capital
- 326
- Contingent Liabilities
- 773
- Book Value per Share
- 383.52
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 92
- 3,100
- 952
- Trade Payables
- 485
- 302
- Total Liabilities
- 4,931
- 756
- Capital Work in Progress
- 66
- 1,848
- 432
- 1,453
- Cash & Bank
- 30
- 346
- Total Assets
- 4,931
- Total Debt
- 1,156
- Net Working Capital
- 516
- Contingent Liabilities
- 205
- Book Value per Share
- 346.37
- Face Value
- 10.00
- Total Debt
- 1,156
- Net Working Capital
- 516
- Contingent Liabilities
- 205
- Book Value per Share
- 346.37
- Face Value
- 10.00
Mar 2026
- Equity Capital
- 92
- 3,191
- 916
- Trade Payables
- 686
- 397
- Total Liabilities
- 5,282
- 785
- Capital Work in Progress
- 84
- 1,868
- 580
- 1,521
- Cash & Bank
- 41
- 402
- Total Assets
- 5,282
- Total Debt
- 1,148
- Net Working Capital
- 534
- Contingent Liabilities
- 166
- Book Value per Share
- 356.17
- Face Value
- 10.00
- Total Debt
- 1,148
- Net Working Capital
- 534
- Contingent Liabilities
- 166
- Book Value per Share
- 356.17
- Face Value
- 10.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 412 | 66 | 40 | 138 | 283 | -283 | 242 | -14 | 421 | 278 | |
| Cash from Investing | -344 | 447 | -166 | 63 | -276 | 19 | -183 | -70 | -138 | -69 |
| Cash from Financing | -67 | -707 | 123 | -204 | -49 | 251 | 11 | 93 | -370 | -199 |
| 0 | -194 | -3 | -3 | -42 | -13 | 70 | 10 | -86 | 10 | |
| Free Cash Flow | 180 | 66 | -16 | -57 | 203 | -348 | 202 | -333 | 393 | 160 |
| OCF / Net Profit | 2.71 | 0.42 | 0.35 | 1.14 | 3.61 | -1.57 | 51.63 | 0.58 | 7.12 | 1.51 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 376 | -152 | -16 | -333 | 117 | 74 |
| OCF / Net Profit | 2.71 | 0.42 | 0.35 | 1.14 | 3.61 | -1.57 | 51.63 | 0.58 | 7.12 | 1.51 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 376 | -152 | -16 | -333 | 117 | 74 |
Mar 2017
- 412
- Cash from Investing
- -344
- Cash from Financing
- -67
- 0
- Free Cash Flow
- 180
- OCF / Net Profit
- 2.71
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.71
- Cumulative 5-Year FCF
- 0
Mar 2018
- 66
- Cash from Investing
- 447
- Cash from Financing
- -707
- -194
- Free Cash Flow
- 66
- OCF / Net Profit
- 0.42
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.42
- Cumulative 5-Year FCF
- 0
Mar 2019
- 40
- Cash from Investing
- -166
- Cash from Financing
- 123
- -3
- Free Cash Flow
- -16
- OCF / Net Profit
- 0.35
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.35
- Cumulative 5-Year FCF
- 0
Mar 2020
- 138
- Cash from Investing
- 63
- Cash from Financing
- -204
- -3
- Free Cash Flow
- -57
- OCF / Net Profit
- 1.14
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.14
- Cumulative 5-Year FCF
- 0
Mar 2021
- 283
- Cash from Investing
- -276
- Cash from Financing
- -49
- -42
- Free Cash Flow
- 203
- OCF / Net Profit
- 3.61
- Cumulative 5-Year FCF
- 376
- OCF / Net Profit
- 3.61
- Cumulative 5-Year FCF
- 376
Mar 2022
- -283
- Cash from Investing
- 19
- Cash from Financing
- 251
- -13
- Free Cash Flow
- -348
- OCF / Net Profit
- -1.57
- Cumulative 5-Year FCF
- -152
- OCF / Net Profit
- -1.57
- Cumulative 5-Year FCF
- -152
Mar 2023
- 242
- Cash from Investing
- -183
- Cash from Financing
- 11
- 70
- Free Cash Flow
- 202
- OCF / Net Profit
- 51.63
- Cumulative 5-Year FCF
- -16
- OCF / Net Profit
- 51.63
- Cumulative 5-Year FCF
- -16
Mar 2024
- -14
- Cash from Investing
- -70
- Cash from Financing
- 93
- 10
- Free Cash Flow
- -333
- OCF / Net Profit
- 0.58
- Cumulative 5-Year FCF
- -333
- OCF / Net Profit
- 0.58
- Cumulative 5-Year FCF
- -333
Mar 2025
- 421
- Cash from Investing
- -138
- Cash from Financing
- -370
- -86
- Free Cash Flow
- 393
- OCF / Net Profit
- 7.12
- Cumulative 5-Year FCF
- 117
- OCF / Net Profit
- 7.12
- Cumulative 5-Year FCF
- 117
Mar 2026
- 278
- Cash from Investing
- -69
- Cash from Financing
- -199
- 10
- Free Cash Flow
- 160
- OCF / Net Profit
- 1.51
- Cumulative 5-Year FCF
- 74
- OCF / Net Profit
- 1.51
- Cumulative 5-Year FCF
- 74
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 16.99 | 17.48 | 12.78 | 13.43 | 8.72 | 20.07 | 0.52 | -2.64 | 6.42 | 19.92 |
| Book Value (₹) | 360.50 | 352.29 | 362.84 | 352.04 | 361.65 | 379.13 | 380.46 | 383.52 | 346.37 | 356.17 |
| Dividend per Share (₹) | 4.50 | 2.00 | 3.00 | 14.00 | 2.50 | 0.00 | 1.50 | 2.50 | 4.00 | 5.00 |
| Cash EPS (₹) | 24.82 | 26.17 | 22.05 | 23.95 | 19.80 | 31.69 | 10.89 | 6.87 | 15.60 | 29.82 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 24.59% | 24.04% | 16.50% | 17.59% | 14.88% | 10.11% | 9.84% | 7.60% | 11.75% | 9.27% |
| Net Margin % | 11.00% | 10.65% | 7.44% | 7.11% | 4.21% | 9.10% | 0.25% | -1.30% | 2.77% | 8.42% |
| ROE % | 4.77% | 4.91% | 3.57% | 3.76% | 2.45% | 5.42% | 0.14% | -0.70% | 1.76% | 5.67% |
| ROCE % | 5.34% | 5.72% | 4.27% | 5.03% | 4.35% | 2.18% | 1.56% | 2.34% | 4.71% | 7.22% |
| 2.83% | 3.23% | 2.60% | 2.63% | 1.61% | 3.43% | 0.09% | -0.43% | 1.10% | 3.60% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 163 | 123 | 122 | 134 | 145 | 195 | 256 | 281 | 257 | 249 |
| Inventory Days | 104 | 84 | 88 | 101 | 113 | 111 | 99 | 97 | 79 | 85 |
| Payable Days | 240 | 201 | 187 | 204 | 226 | 228 | 220 | 224 | 173 | 192 |
| 27 | 6 | 24 | 30 | 32 | 78 | 135 | 154 | 164 | 141 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.50x | 0.19x | 0.25x | 0.27x | 0.27x | 0.37x | 0.39x | 0.46x | 0.36x | 0.35x |
| Interest Coverage (x) | 3.54x | 3.00x | 3.09x | 3.04x | 2.71x | 1.29x | 0.53x | 0.84x | 1.54x | 2.79x |
| 1.80x | 1.33x | 1.20x | 0.96x | 1.10x | 1.07x | 1.18x | 1.16x | 1.32x | 1.29x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | -37.80% | 6.35% | 4.62% | 10.05% | 9.79% | 6.54% | -6.29% | 0.63% | 14.65% | 1.90% |
| Operating Profit Growth % | -10.29% | 3.98% | -28.20% | 17.30% | -7.13% | -27.58% | -8.78% | 14.61% | 47.52% | 32.23% |
| Net Profit Growth % | 15.16% | 2.97% | -26.87% | 5.13% | -34.95% | 130.30% | -97.40% | -618.48% | 343.69% | 210.43% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -609.47% | 342.99% | 210.39% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 104.23x | 47.07x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 2.04x | 1.93x | 2.63x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.32% | 0.60% | 0.53% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 41.63x | 23.63x | 23.89x |
Mar 2017
- EPS (₹)
- 16.99
- Book Value (₹)
- 360.50
- Dividend per Share (₹)
- 4.50
- Cash EPS (₹)
- 24.82
- Operating Margin %
- 24.59%
- Net Margin %
- 11.00%
- ROE %
- 4.77%
- ROCE %
- 5.34%
- 2.83%
- Debtor Days
- 163
- Inventory Days
- 104
- Payable Days
- 240
- 27
- Debt to Equity (x)
- 0.50x
- Interest Coverage (x)
- 3.54x
- 1.80x
- Revenue Growth %
- -37.80%
- Operating Profit Growth %
- -10.29%
- Net Profit Growth %
- 15.16%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- 17.48
- Book Value (₹)
- 352.29
- Dividend per Share (₹)
- 2.00
- Cash EPS (₹)
- 26.17
- Operating Margin %
- 24.04%
- Net Margin %
- 10.65%
- ROE %
- 4.91%
- ROCE %
- 5.72%
- 3.23%
- Debtor Days
- 123
- Inventory Days
- 84
- Payable Days
- 201
- 6
- Debt to Equity (x)
- 0.19x
- Interest Coverage (x)
- 3.00x
- 1.33x
- Revenue Growth %
- 6.35%
- Operating Profit Growth %
- 3.98%
- Net Profit Growth %
- 2.97%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 12.78
- Book Value (₹)
- 362.84
- Dividend per Share (₹)
- 3.00
- Cash EPS (₹)
- 22.05
- Operating Margin %
- 16.50%
- Net Margin %
- 7.44%
- ROE %
- 3.57%
- ROCE %
- 4.27%
- 2.60%
- Debtor Days
- 122
- Inventory Days
- 88
- Payable Days
- 187
- 24
- Debt to Equity (x)
- 0.25x
- Interest Coverage (x)
- 3.09x
- 1.20x
- Revenue Growth %
- 4.62%
- Operating Profit Growth %
- -28.20%
- Net Profit Growth %
- -26.87%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 13.43
- Book Value (₹)
- 352.04
- Dividend per Share (₹)
- 14.00
- Cash EPS (₹)
- 23.95
- Operating Margin %
- 17.59%
- Net Margin %
- 7.11%
- ROE %
- 3.76%
- ROCE %
- 5.03%
- 2.63%
- Debtor Days
- 134
- Inventory Days
- 101
- Payable Days
- 204
- 30
- Debt to Equity (x)
- 0.27x
- Interest Coverage (x)
- 3.04x
- 0.96x
- Revenue Growth %
- 10.05%
- Operating Profit Growth %
- 17.30%
- Net Profit Growth %
- 5.13%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 8.72
- Book Value (₹)
- 361.65
- Dividend per Share (₹)
- 2.50
- Cash EPS (₹)
- 19.80
- Operating Margin %
- 14.88%
- Net Margin %
- 4.21%
- ROE %
- 2.45%
- ROCE %
- 4.35%
- 1.61%
- Debtor Days
- 145
- Inventory Days
- 113
- Payable Days
- 226
- 32
- Debt to Equity (x)
- 0.27x
- Interest Coverage (x)
- 2.71x
- 1.10x
- Revenue Growth %
- 9.79%
- Operating Profit Growth %
- -7.13%
- Net Profit Growth %
- -34.95%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 20.07
- Book Value (₹)
- 379.13
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 31.69
- Operating Margin %
- 10.11%
- Net Margin %
- 9.10%
- ROE %
- 5.42%
- ROCE %
- 2.18%
- 3.43%
- Debtor Days
- 195
- Inventory Days
- 111
- Payable Days
- 228
- 78
- Debt to Equity (x)
- 0.37x
- Interest Coverage (x)
- 1.29x
- 1.07x
- Revenue Growth %
- 6.54%
- Operating Profit Growth %
- -27.58%
- Net Profit Growth %
- 130.30%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 0.52
- Book Value (₹)
- 380.46
- Dividend per Share (₹)
- 1.50
- Cash EPS (₹)
- 10.89
- Operating Margin %
- 9.84%
- Net Margin %
- 0.25%
- ROE %
- 0.14%
- ROCE %
- 1.56%
- 0.09%
- Debtor Days
- 256
- Inventory Days
- 99
- Payable Days
- 220
- 135
- Debt to Equity (x)
- 0.39x
- Interest Coverage (x)
- 0.53x
- 1.18x
- Revenue Growth %
- -6.29%
- Operating Profit Growth %
- -8.78%
- Net Profit Growth %
- -97.40%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- -2.64
- Book Value (₹)
- 383.52
- Dividend per Share (₹)
- 2.50
- Cash EPS (₹)
- 6.87
- Operating Margin %
- 7.60%
- Net Margin %
- -1.30%
- ROE %
- -0.70%
- ROCE %
- 2.34%
- -0.43%
- Debtor Days
- 281
- Inventory Days
- 97
- Payable Days
- 224
- 154
- Debt to Equity (x)
- 0.46x
- Interest Coverage (x)
- 0.84x
- 1.16x
- Revenue Growth %
- 0.63%
- Operating Profit Growth %
- 14.61%
- Net Profit Growth %
- -618.48%
- -609.47%
- P/E (x)
- 0.00x
- P/B (x)
- 2.04x
- Dividend Yield %
- 0.32%
- 41.63x
Mar 2025
- EPS (₹)
- 6.42
- Book Value (₹)
- 346.37
- Dividend per Share (₹)
- 4.00
- Cash EPS (₹)
- 15.60
- Operating Margin %
- 11.75%
- Net Margin %
- 2.77%
- ROE %
- 1.76%
- ROCE %
- 4.71%
- 1.10%
- Debtor Days
- 257
- Inventory Days
- 79
- Payable Days
- 173
- 164
- Debt to Equity (x)
- 0.36x
- Interest Coverage (x)
- 1.54x
- 1.32x
- Revenue Growth %
- 14.65%
- Operating Profit Growth %
- 47.52%
- Net Profit Growth %
- 343.69%
- 342.99%
- P/E (x)
- 104.23x
- P/B (x)
- 1.93x
- Dividend Yield %
- 0.60%
- 23.63x
Mar 2026
- EPS (₹)
- 19.92
- Book Value (₹)
- 356.17
- Dividend per Share (₹)
- 5.00
- Cash EPS (₹)
- 29.82
- Operating Margin %
- 9.27%
- Net Margin %
- 8.42%
- ROE %
- 5.67%
- ROCE %
- 7.22%
- 3.60%
- Debtor Days
- 249
- Inventory Days
- 85
- Payable Days
- 192
- 141
- Debt to Equity (x)
- 0.35x
- Interest Coverage (x)
- 2.79x
- 1.29x
- Revenue Growth %
- 1.90%
- Operating Profit Growth %
- 32.23%
- Net Profit Growth %
- 210.43%
- 210.39%
- P/E (x)
- 47.07x
- P/B (x)
- 2.63x
- Dividend Yield %
- 0.53%
- 23.89x
Documents
Announcements
- Press Release
2026-08-19 - Strides Pharma Science Limited has informed the Exchange regarding a press release dated August 19, 2026, titled "Strides receives USFDA Establishment Inspection Report (EIR) for flagship facility in Bengaluru".
- Shareholders meeting
2026-08-18 - Strides Pharma Science Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 14, 2026. Further, the company has informed the Exchange regarding voting results.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Jul 2026
May 2026
Feb 2026